Trials / Completed
CompletedNCT00018200
Effect of Antidepressants on Back Pain
Efficacy of Antidepressants in Chronic Back Pain
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- US Department of Veterans Affairs · Federal
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether different types of antidepressant medicines relieve back pain that has lasted at least six months on a daily basis. Study participants will be assigned to treatment with either a antidepressant acting on the serotonin system in the brain (fluoxetine), one acting on the noradrenaline system (desipramine, or to a control medication not expected to relieve pain (benztropine). Each participant will be seen at least nine times during their 12 weeks on medication. This is a phase 2/3, outpatient study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desipramine | Low exposure (40-70 ng/mL), Middle exposure (70-130 ng/mL), High exposure (130-200 ng/mL) |
| DRUG | Fluoxetine | Low exposure (200-399 ng/mL), Middle exposure (400-499 ng/mL), High exposure (500-700ng/mL) |
| DRUG | Benztropine | Daily dose 0.125 to 0.5mg |
Timeline
- Start date
- 1999-04-01
- Primary completion
- 2003-12-01
- Completion
- 2004-03-01
- First posted
- 2001-07-05
- Last updated
- 2012-06-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00018200. Inclusion in this directory is not an endorsement.